Dose-response Relationship of Botullinum Toxin (DWP 450) for Finger Flexor Spasticity

NCT03517319 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Spasticity as Sequela of Stroke

Interventions

DRUG: Normal Saline 0.9% 1.2 ml
DRUG: Clostridium Botulinum Toxin Type A (Nabota, DWP 450) 15 U
DRUG: Clostridium Botulinum Toxin Type A (Nabota, DWP 450) 30 U
DRUG: Clostridium Botulinum Toxin Type A (Nabota, DWP 450) 50 U
DRUG: Clostridium Botulinum Toxin Type A (Nabota, DWP 450) 70 U

Sponsor

Seoul National University Hospital

Collaborators

[object Object]